North America Analgesics Market to Reach USD 32.2 Billion by 2033, Propelled by Growing Incidences of Chronic Diseases

January 24, 2025 | Healthcare

According to the latest report by IMARC Group, titled “North America Analgesics Market Report by Type (Prescription Analgesics, OTC Analgesics), Drug Class (Opioids, NSAID, and Others), Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), Pain Type (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine, Obstetrical Pain, Fibromyalgia, Pain due to Burns, Dental/Facial Pain, Pediatric Pain, and Others), Application (Internal Analgesics, External Analgesics), and Country 2025-2033”, the North America analgesics market size reached USD 24.9 Billion in 2024. Analgesics, also known as painkillers, refer to any drugs that are used to achieve analgesia or pain relief. The peripheral nervous system and the central nervous system are affected differently by analgesic drugs. Their primary action is either to reduce inflammation (swelling) or to change the way the brain perceives pain. When taken for pain relief, analgesics can alleviate chronic diseases, injuries, or inflammation. Due to this, they are typically used to induce cooperation during medical procedures. Depending on their intensity, they are able to treat moderate to severe pain.

North America Analgesics Market Trends:

The market in North America is majorly driven by the growing incidences of chronic diseases leading to a growing number of people suffering from severe chronic pain. This can be attributed to the expanding geriatric population that isa susceptible to developing numerous health issues. In addition to this, increasing clinical studies for assessing the safety and efficacy of a wide range of therapeutic drugs contribute to the growth of the analgesics market. The augmenting number of surgeries, along with the increasing penetration of effective pain management medications, is also providing an impetus to the market. Furthermore, the rising funding from private and government organizations is positively impacting the pharmaceutical manufacturing industry. Some of the other factors contributing to the market include expanding medical expenditure, continual technological advancements in manufacturing advanced analgesic drugs, a considerable increase in demand for over the counter (OTC) drugs and extensive research and development (R&D) activities. Looking forward, the market value is projected to reach USD 32.2 Billion by 2033, expanding at a CAGR of 2.9% during 2025-2033.

Market Summary:

  • Based on the type, the market has been segmented into prescription and OTC analgesics
  • On the basis of the drug class, the market has been divided into opioids, NSAID, and others.
  • Based on the route of administration, the market has been categorized into oral, parenteral, topical, transdermal, and rectal.
  • On the basis of the pain type, the market has been classified into musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine, obstetrical pain, fibromyalgia, pain due to burns, dental/facial pain, pediatric pain, and others.
  • Based on the application, the market has been segmented into internal and external analgesics.
  • On the geographical front, the market has been segregated into the United States, Canada, and Mexico.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players.

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Type, Drug Class, Route of Administration, Pain Type, Application, Country
Countries Covered United States, Canada, Mexico
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
North America Analgesics Market to Reach USD 32.2 Billion by 2033, Propelled by Growing Incidences of Chronic Diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials